An exploratory analysis of brentuximab vedotin plus CHP (A plus CHP) in the frontline treatment of patients with CD30+ peripheral T-cell lymphomas (ECHELON-2): Impact of consolidative stem cell transplant Meeting Abstract
| Authors: | Savage, K. J.; Horwitz, S. M.; Advani, R. H.; Christensen, J. H.; Domingo-Domenech, E.; Rossi, G.; Morschhauser, F.; Alpdogan, O.; Suh, C.; Tobinai, K.; Shustov, A. R.; Trneny, M.; Yuen, S.; Zinzani, P. L.; Truemper, L.; Illidge, T.; O'Connor, O.; Pro, B.; Little, M.; Bunn, V.; Fenton, K.; Manley, T.; Iyer, S. P. |
| Abstract Title: | An exploratory analysis of brentuximab vedotin plus CHP (A plus CHP) in the frontline treatment of patients with CD30+ peripheral T-cell lymphomas (ECHELON-2): Impact of consolidative stem cell transplant |
| Meeting Title: | 61st Annual Meeting and Exposition of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 134 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2019 Dec 7-10 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2019-11-13 |
| Language: | English |
| ACCESSION: | WOS:000518218500567 |
| DOI: | 10.1182/blood-2019-122781 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 464 -- Source: Wos |
